These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28651307)

  • 1. Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
    Jeong JY; Sohn JH; Sohn W; Park CH; Kim TY; Jun DW; Kim Y; Jeong WK
    Gut Liver; 2017 Nov; 11(6):852-859. PubMed ID: 28651307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
    Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
    Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
    Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song KJ; Park YN; Han KH
    Hepatology; 2015 Jun; 61(6):1851-9. PubMed ID: 25643638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Zhang T; Zhang G; Deng X; Zeng J; Jin J; Zeping H; Wu M; Zheng R
    Radiology; 2021 Nov; 301(2):350-359. PubMed ID: 34427463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.
    Song BG; Sinn DH; Chi S; Kim K; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1447-1452. PubMed ID: 30063482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
    Kim BS; Seo YS; Kim YS; Lee CH; Lee HA; Um SH; Yoo JJ; Kim SG; Suh SJ; Jung YK; Ahn SH; Han KH; Yim HJ; Kim SU;
    J Gastroenterol Hepatol; 2018 Feb; 33(2):503-510. PubMed ID: 28666070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song K; Han KH
    Medicine (Baltimore); 2016 May; 95(20):e3434. PubMed ID: 27196449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.
    Shin SH; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim BK
    Liver Int; 2015 Mar; 35(3):1054-62. PubMed ID: 24930484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
    Zhang Y; Wang C; Li H; Ding Y
    Medicine (Baltimore); 2019 Jan; 98(3):e13929. PubMed ID: 30653099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy.
    Seo YS; Kim MN; Kim SU; Kim SG; Um SH; Han KH; Kim YS
    Medicine (Baltimore); 2016 Mar; 95(12):e2985. PubMed ID: 27015173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.
    Kim MN; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
    J Clin Gastroenterol; 2014 Mar; 48(3):272-8. PubMed ID: 23811938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
    Jung KS; Kim SU; Ahn SH; Park YN; Kim DY; Park JY; Chon CY; Choi EH; Han KH
    Hepatology; 2011 Mar; 53(3):885-94. PubMed ID: 21319193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication.
    Nakai M; Yamamoto Y; Baba M; Suda G; Kubo A; Tokuchi Y; Kitagataya T; Yamada R; Shigesawa T; Suzuki K; Nakamura A; Sho T; Morikawa K; Ogawa K; Furuya K; Sakamoto N
    Sci Rep; 2022 Jan; 12(1):1449. PubMed ID: 35087141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.
    Mak LY; Hui RW; Fung J; Liu F; Wong DK; Li B; Cheung KS; Yuen MF; Seto WK
    Hepatol Int; 2021 Aug; 15(4):901-911. PubMed ID: 34152534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B.
    Jeon MY; Lee HW; Kim SU; Kim BK; Park JY; Kim DY; Han KH; Ahn SH
    Liver Int; 2018 Apr; 38(4):676-686. PubMed ID: 28865176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
    Heo JY; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Park YN; Ahn SS; Han KH; Kim HS
    Medicine (Baltimore); 2016 Apr; 95(14):e3328. PubMed ID: 27057911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver and spleen stiffness and their ratio assessed by real-time two dimensional-shear wave elastography in patients with liver fibrosis and cirrhosis due to chronic viral hepatitis.
    Grgurevic I; Puljiz Z; Brnic D; Bokun T; Heinzl R; Lukic A; Luksic B; Kujundzic M; Brkljacic B
    Eur Radiol; 2015 Nov; 25(11):3214-21. PubMed ID: 25903706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Chon YE; Park JY; Myoung SM; Jung KS; Kim BK; Kim SU; Kim DY; Ahn SH; Han KH
    Am J Gastroenterol; 2017 Jun; 112(6):882-891. PubMed ID: 28374814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative noninvasive assessment for liver fibrosis in hepatocellular carcinoma patients with chronic hepatitis B: Comparison of two-dimensional shear-wave elastography with serum liver fibrosis models.
    Chen S; Jiang T
    Eur J Radiol; 2020 Dec; 133():109386. PubMed ID: 33160197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessment.
    Nakagomi R; Tateishi R; Masuzaki R; Soroida Y; Iwai T; Kondo M; Fujiwara N; Sato M; Minami T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Kondo Y; Tanaka Y; Otsuka M; Kato N; Moriya K; Ikeda H; Koike K
    J Gastroenterol Hepatol; 2019 May; 34(5):921-928. PubMed ID: 30393960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.